Additional Content Download

Infographic: Building a better biobank - invest in the future

Infographic: Building a better biobank - invest in the future

The biobanking landscape is changing rapidly to deal with the increasing demands of the systems biology community. The UK biobank highlights the continuing advances in the research field with the recent opening of nearly 20TB(terabytes) of data from half a million individuals. Researchers from across the globe will be able to make use this - anonymised - data in their work.


Compound Management: The Ever-Changing Role of CROs

Compound Management: The Ever-Changing Role of CROs

In this interview, Rose Gonzales, who is a director at Pfizer, joins us to talk about the ever-changing role of CROs as well as the effective utilisation of strong compound management within the drug discovery process. 
Global Guide to Biobanking

Global Guide to Biobanking

Pharma IQ in conjunction with the 8th Annual Global Biobanking prepared this Global Guide to Biobanking, the definitive resource for professionals in the biobanking area. The guide summarizes the key issues related to new disposable solutions in biomanufacturing, current failures and new models of consent and recent commercial and technological trends in biobanking area.

Expanding sample libraries tops the wish list for compound and sample managers

Expanding sample libraries tops the wish list for compound and sample managers

This report based on the results of the Annual Compound & Sample Management survey of key members of the compound management community gauged their current concerns and future plans. Download the report to read the results.
Use of Digital and Acoustic Technologies for Low Volume Dispensing Data

Use of Digital and Acoustic Technologies for Low Volume Dispensing Data

Mark Wigglesworth, Lead Optimisation, Sample Management Technologies, GlaxoSmithKline

This presentation examines the use of digital dispense technology within a screening environment, demonstrates the dispense of a large set of compounds using the Digital dispense technology, looks at the use of the Acoustic technology within GSK and describes the dispense of non-DMSO solutions in low volume.
Balancing Efficiency, Quality, and Flexibility in Lead Optimisation Sample Management

Balancing Efficiency, Quality, and Flexibility in Lead Optimisation Sample Management

C.K. Chan, Senior Principal Scientist, Compound Management and Distribution, Pfizer

This presentation looks at this from small molecules to peptides, from single stock concentration to project specific concentration, from site-based model to global/CRO support and ensure quality with sample QC.
Building an Effective  Informatics System at UK Biobank - An Interview with James Brennan

Building an Effective Informatics System at UK Biobank - An Interview with James Brennan

We spoke with James Brennan, Informatics Lead at the UK Biocentre about integrating their sample ordering system with an existing LIMS. We also spoke about the challenges involved in a sample ordering system; such as large scale ordering and ensuring the correct spread with regard to sample attributes.

Is Your Biobank Lean?

Is Your Biobank Lean?


Jon Wetzel, founder of the Lean for Everyone blog, joins Andrea Charles from Pharma IQ to discuss recent technological and commercial trends in the biobanking sector. Pharma IQ: What technological and commercial trends have you seen in the biobanking sector recently? J Wetzel: I think we’ve seen a slow shift from the big experiment to the smaller, discrete datasets that are more cus.... Learn more

Futureproof your Biobank - An Interview with Kathi Shea

Futureproof your Biobank - An Interview with Kathi Shea

We spoke to Kathi Shea, former President of ISBER and Vice President BioServices, Precision for medicine. Kathi spoke about procedures and training increase the value of samples and data being collected and also gave us her key to comprehensive planning.

Inside Development of Lundbeck’s Inhouse Global Compound Management and Compound Ordering System - An Interview with Claus Stie Kallesøe

Inside Development of Lundbeck’s Inhouse Global Compound Management and Compound Ordering System - An Interview with Claus Stie Kallesøe

Creating a fit-for-purpose compound management and compound ordering system is a huge task, so often the best way to understand is to look at those who have done it before. We spoke to Claus Stie Kallesøe, Head of Research Informatics at Lundbeck about his experiences in this task and how it was completed from inception to completion. Claus also describes the challenges involved and how flexible a system has to be to deal with all that is expected of it from compound ordering to dealing with multiple data sources.

The Road To ‘Personalised Medicine’ and the rules of good biobanking with AstraZeneca's Duncan McHale, Vice-President for Personalised Healthcare and Biomarkers

The Road To ‘Personalised Medicine’ and the rules of good biobanking with AstraZeneca's Duncan McHale, Vice-President for Personalised Healthcare and Biomarkers

Duncan McHale, Vice-President for Personalised Healthcare and Biomarkers, Astrazeneca, joins Helen Winsor of Pharma IQ. In this interview he discusses the importance of biomarker discovery & validation, how close we are to ‘Personalised Medicine’, why sample quality is key, the rules of good biobanking, how we can improve biomarker research, what we should change and why, what’s stopping us bringing change and his top 3 priorities for the next 12 months.

President of ISBER: Looking to the Future of Biospecimen Science

President of ISBER: Looking to the Future of Biospecimen Science

Kathi Shea, President at ISBER 2012-2013, discusses the goals for ISBER in  2013. She also explains the challenges experienced by the biorepository community around standardisation and harmonisation and looks to what the future will bring to biospecimen science.

Sample Delegate List

Download the sample delegate list to see who is in attendance at this year's Compound and Biobanking Summit